Josh Smith began their work experience in 2020 at Rothschild & Co as an Investment Banking Associate. In 2022, they joined Redburn as a Healthcare Equity Research Analyst on secondment.
Josh Smith started their education at Dartford Grammar School from 2003 to 2010, where they completed their secondary education. Josh then pursued a Bachelor of Science degree in Medicinal and Pharmaceutical Chemistry from Loughborough University, graduating in 2015. In 2015, they enrolled at the University of Oxford, where they obtained a Master of Science degree in Pharmacology the following year. Josh subsequently continued their studies at the University of Oxford, completing a DPhil (PhD) in Pharmacology in 2020.
This person is not in the org chart
Redburn
1 followers
Intelligence is essential for active fund managers and corporates. As part of the Rothschild & Co group, Redburn’s purpose in Research, Execution and Equity Capital Markets is to help all our clients make better investments. Redburn is built upon a commitment to intellectual freedom, commercial research, best execution and premium client service. We were founded in 2003, and have grown from 14 employees to over 200 based in London, Paris, Madrid, New York and Boston. We provide institutional investors with equity research, quantitative and technical analysis, economics research and agency execution in European and North American equity markets, and serve corporates via our Equity Capital Markets division. In addition, Redburn Access also links investors to Redburn's network of industry executives and independent experts.